| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1971612 | Clinical Biochemistry | 2008 | 9 Pages |
ObjectivesExpression of human HtrA1, HtrA2, HtrA3 and TGF-β1 genes was examined in ovarian tissue specimens including 19 normal ovaries, 20 benign tumors, 7 borderline tumors, 44 cancers and 8 Krukenberg tumors.Design and methodsmRNA and protein levels were evaluated by semi-quantitative RT-PCR and Western-blotting methods, respectively.ResultsA statistically significant decrease of HtrA1 and HtrA3 expression in ovarian tumors comparing to normal tissues was observed. A dramatic decrease of HtrA3 mRNA and protein levels in all tumor tissue groups, and a loss of HtrA3 protein in 30% malignant tumors were found. A significant decrease of HtrA1 mRNA, and of HtrA3 mRNA and protein in malignant tumors compared to benign tumors was revealed. HtrA2 expression in tumor tissues was slightly decreased. Expression of TGF-β1 in tumor tissues was not significantly different compared to control tissues.ConclusionsOur results show downregulation of HtrA1 and HtrA3 genes' expression in different types of ovarian tumors and give additional evidence that these genes may function as tumor suppressors.
